The novel extended-release formulation is expected to prevent both acute and delayed CINV for up to 5 days, improving patient compliance and convenience.
Over the course of the patient's treatment, there were opportunities to recognize the error and prevent the patient's catastrophic results.
Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA vs those not on a GLP-1 RA.
Affected patients should not stop taking their medication suddenly but should contact their doctor or pharmacy immediately.
HealthDay News — The prevalence of chronic kidney disease (CKD) is increasing globally, according to a study published online November 7 in The Lancet to coincide with Kidney Week, the annual meeting ...
HealthDay News — Federal health officials have announced a recall for ByHeart Whole Nutrition Infant Formula after a multi-state outbreak of infant botulism. Although botulism can be fatal, no deaths ...
HealthDay News — For patients with acute coronary syndrome, targeted vitamin D 3 supplementation is associated with a reduced risk for follow-up myocardial infarction, according to a study presented ...
A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...
(HealthDay News) — Long-term melatonin use for treatment of insomnia is associated with a higher risk for incident heart failure and all-cause mortality, according to a study to be presented at the ...
Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...
The Agency’s shift on HRT was based on a comprehensive review of data that assessed its benefits and risks since the publication of the Women’s Health Initiative trials.
(HealthDay News) — A peanut patch treatment ( Viaskin Peanut Patch; [VP250]) continues to help toddlers safely build tolerance to peanuts over 3 years, according to a study presented at the annual ...